Diversity by Design: Ensuring More Inclusive Studies with TriNetX Real-World Data
Having representative patient populations in your trial designs is crucial to understanding disease and designing successful clinical trials. Evaluating patient eligibility criteria and its impact on enrollment helps us anticipate and adjust these criteria when it’s most crucial: before your study even begins.
Stream our webinar, aired on June 13th to hear from Beth Brooks, Head of Patient Insights and Behavioral Sciences at Sanofi, who will share how utilizing TriNetX has improved her team’s research outcomes from protocol to results. We will also be joined by a member of our TriNetX Clinical Feasibility & Analytics team to share best practices when querying diverse patient populations.
Presenters:
Beth Brooks, MPH
Head, Patient Insights & Behavioral Sciences
Sanofi
Isatu Kargbo
Senior Analyst, Clinical Feasibility & Analytics
TriNetX
Jim Phillips
VP Account Management
TriNetX